Merck (MRK) Share-based Compensation (2016 - 2025)
Historic Share-based Compensation for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $204.0 million.
- Merck's Share-based Compensation rose 461.54% to $204.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $802.0 million, marking a year-over-year increase of 823.21%. This contributed to the annual value of $761.0 million for FY2024, which is 1798.45% up from last year.
- Latest data reveals that Merck reported Share-based Compensation of $204.0 million as of Q3 2025, which was up 461.54% from $216.0 million recorded in Q2 2025.
- Merck's Share-based Compensation's 5-year high stood at $216.0 million during Q2 2025, with a 5-year trough of $111.0 million in Q1 2021.
- For the 5-year period, Merck's Share-based Compensation averaged around $160.1 million, with its median value being $164.0 million (2023).
- Per our database at Business Quant, Merck's Share-based Compensation crashed by 714.29% in 2021 and then skyrocketed by 2335.77% in 2023.
- Merck's Share-based Compensation (Quarter) stood at $119.0 million in 2021, then grew by 21.85% to $145.0 million in 2022, then increased by 15.17% to $167.0 million in 2023, then increased by 11.98% to $187.0 million in 2024, then increased by 9.09% to $204.0 million in 2025.
- Its Share-based Compensation was $204.0 million in Q3 2025, compared to $216.0 million in Q2 2025 and $195.0 million in Q1 2025.